Board of Directors
Pontus Ottosson
Born: 1960
Education: Master of Science, Chalmers University of Technology in Gothenburg
Other assignments: Head of Investments at Chalmers Ventures AB. Chairman of the Board in IPS Particle Technology Sweden AB, Board member in Oxeon AB, InSingulo AB, Industrial Path Solutions AB, AnPrima AB and Prigo AB.
Work experience: Former CEO of Aqilion (former P.U.L.S) and DuoCort Pharma AB and Board member in several start-up companies within Life Science and Tech.
Holdings: 258,750 shares, 0 warrants
Independent in relation to LIDDS AB (publ), its management and the principal shareholders.
David Bejker
Born: 1975
Education: MSc from the Stockholm School of Economics
Other assignments: CEO of Affibody Medical AB and board member of Abliva AB and Amylonix AB
Work experience: CEO of Affibody Medical AB, a company that develops innovative protein drugs, since 2008. Previously at HealthCap, a specialized life science investor.
Holdings: 65,000 shares, 0 warrants
Independent in relation to LIDDS AB (publ), its management and the principal shareholders
Daniel Lifveredson
Born: 1976
Education: Master of Science in Industrial Engineering and Management, Chalmers University of Technology in Gothenburg
Other assignments: CEO and owner of Excore AB
Work experience: Worked with Excore as a base since 1998. Excore is active in advising corporate transactions in the segment of medium-sized companies. Long experience in international business. In addition to Excore, Daniel Lifveredson is involved as a partner in a number of businesses.
Holdings: 2,790,929 shares, 0 warrants
Independent in relation to LIDDS AB (publ), its management and the principal shareholders
Johan Lund
Born: 1957
Education: MD/PhD Karolinska Institute, Stockholm.
Other assignments: Co-Founder of KyNexis Medicine Development AB and founder of MBS Pharma, CSO and Chairman of the Board of Aqilion, Chairman of the Board of NEOGAP Therapeutics AB, board member and chairman of the remuneration committee of Olink Holding (Nasdaq NYC), board member of Genagon Therapeutics AB and Pelago Bioscience AB.
Work Experience: Former VP of Immunology & Inflammation Research & Early Development, Celgene; SVP and CSO of Immunology & Inflammation, Pfizer; VP of CNS & Pain Research, AstraZeneca and VP Respiratory & Inflammation Research, AstraZeneca. Professor & Chairman, Department of Anatomy & Cell Biology, Medical Faculty, University of Bergen; Associate Professor, Department of Medical Nutrition, Karolinska Institute.
Holdings: 40,180 Shares
Independent in relation to LIDDS AB (publ), its management and the principal shareholders